Search Results for "Mirrx Therapeutics"
Original Source: Mirrx Therapeutics
Mirrx Therapeutics is developing a novel microRNA-blocking technology, Blockmirs, which are antisense oligonucleotides that bind to a microRNA binding site on an mRNA. This unique approach blocks single microRNA:mRNA interactions, resulting in extremely targeted regulation of specific mRNAs, thereby potentially reducing unintended effects on gene activity. www.mirrx.com
Matching PubMed Articles